Loading news...
Loading news...
Adaptive Phage Therapeutics raised $24M Series B venture round, led by AMR Action Fund.
This funding round does not have an about section yet.
| Investor | Firm Type |
|---|
| Partner |
|---|
AMR Action FundLEAD | Venture Capital | — |
| Venture Capital | — |
This company has completed 4 funding rounds. Current round is highlighted.
Total Raised
$92M
Top Valuation
-
Adaptive Phage Therapeutics raised $24M in a Series B round.
The round was announced on 06/13/23.
The round was led by AMR Action Fund, Ian Hardy.